(BFM Bourse) – The decline of biotech intensifies, Pixium now drop more than 30% over the last five sessions and 40% over a month, with no particular relevance. A movement whose financial director admits he does not understand the outcome, which leads him to question the future of the sector but also future of Euronext.

Read more (French) »